ArticleKidney international supplements2013
Hypertension in women.
Article in Kidney international supplements, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 34 citations in OpenAlex.
- Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension from the Systolic Blood Pressure Intervention Trial.Journal of hypertension · 2018Trial
- Oral Conditions, Salivary pH, Flow Rate, Phosphate Level, and Phosphorus Intake of Pre- and Postmenopausal Women.European journal of dentistry · 2025Article
- Prevalence and predictors of risk factors for cardiovascular diseases among women aged 15-49 years across urban and rural India: findings from a nationwide survey.BMC women's health · 2024Article
- Ovariectomy Via 12/15-lipoxygenase Augments Angiotensin II-Induced Hypertension and Its Pathogenesis in Female Mice.Hypertension (Dallas, Tex. : 1979) · 2023Article
- Atrial fibrillation patterns and their cardiovascular risk profiles in the general population: the Rotterdam study.Clinical research in cardiology : official journal of the German Cardiac Society · 2023Article
- The Representation of Females in Studies on Antihypertensive Medication over the Years: A Scoping Review.Biomedicines · 2023Article
- Prevalence and factors associated with hypertension among older people living with HIV in South Africa.BMC public health · 2022Article
- Risk Factors for Coronary Heart Disease Among Lebanese Women: A Case-Control Study.Vascular health and risk management · 2022Article
- Prevalence and associated factors of undiagnosed hypertension among women aged 15-49 years in India: an analysis of National Family Health Survey-4 data.Journal of human hypertension · 2021Article
- Efficacy and safety of nebivolol in Korean patients with hypertension by age and sex: a subanalysis from the BENEFIT-KOREA study.Clinical hypertension · 2021Article
- Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists.European heart journal · 2021Article
- Cardiovascular Outcomes in Advanced Maternal Age Delivering Women. Clinical Review and Medico-Legal Issues.Medicina (Kaunas, Lithuania) · 2019Review
- Prevalence of hypertension and its associated factors among adults in Debre Markos Town, Northwest Ethiopia: community based cross-sectional study.BMC research notes · 2019Article
- The Gender Impact on Morphogenetic Variability in Coronary Artery Disease: A Preliminary Study.Journal of clinical medicine · 2018Article
- Hypertension Across a Woman's Life Cycle.Journal of the American College of Cardiology · 2018Review
- The association between high-sensitivity C-reactive protein and hypertension in women of the CARDIA study.Menopause (New York, N.Y.) · 2016Article
- Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question).Current hypertension reports · 2016Review
- Sex-Specific Effect of Endothelin in the Blood Pressure Response to Acute Angiotensin II in Growth-Restricted Rats.Hypertension (Dallas, Tex. : 1979) · 2015Article
- Prevalence of hypertension links with body mass index by academic population in Babylon city.Journal of advanced pharmaceutical technology & researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
Hypertension is the most common modifiable risk factor for cardiovascular disease, the leading cause of death in both men and women. The prevalence and severity of hypertension rise markedly with age, and blood pressure control becomes more difficult with aging in both genders, particularly in women. In addition, there are forms of hypertension that occur exclusively in women, e.g., hypertension related to menopause, oral contraceptive use, or pregnancy (e.g., chronic hypertension, gestational hypertension, pre-eclampsia or eclampsia). Randomized controlled trials show that antihypertensive therapy provides similar reductions in major cardiovascular events in men and women. Therefore, gender should not influence decisions on selection of blood pressure lowering therapies, except for consideration of gender-specific side effects or contraindications for use in women who are or may become pregnant. This article reviews the prevalence, awareness, treatment, and control of hypertension in women, as well as recent guidelines for management of hypertension in women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.